Benign Prostatic Hyperplasia News

Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology , demonstrate long-term safety and tolerability of RAPAFLO A for up to 52 weeks of treatment.

Health news: How alcohol can help prostate problems, the drug that acts fast on heart attacks and fish oil for neck pain By Daily Mail Reporter Last updated at 12:48 AM on 08th December 2009 Health stories from around the world this week include how drinking two pints a day could help men ward off a common prostate issue.

CEO of Urologix Inc. Stryker Jr Warren buys 3,100 shares of ULGX on 12/03/2009 at an average price of $1.12 a share.

Aeterna Zentaris Inc. shares plunged Monday after the Quebec-based company announced that a European drug trial had failed to provide clear evidence that one of its drug candidates is an effective treatment for enlarged prostate glands.

BPH treatment is absolutely natural and has no adverse side effects. Dr Allena s Device for Prostate Treatment provides Thermobalsncing therapy for treatment of Benign Prostatic Hyperplasia, BPH.

Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology Article Date: 06 Dec 2009 The Medicines and Healthcare products Regulatory Agency has announced the approval of the first over-the-counter medicine to treat the symptoms of benign prostatic hyperplasia in men, to be available through pharmacies without a prescription.

By the time they hit their 60th birthdays, half of all men will have a condition called benign Prostatic Hyperplasia, or BPH.

This Prostate treatment relieves the symptoms quickly and naturally. London, UK, November 30, 2009 -- New prostate treatment is available in the United Kingdom for the first time in the world.

Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Therapy Area Pipeline Report - new report released © companiesandmarkets.com companiesandmarkets.com 2009-11-26 11:47:04 - Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Therapy Area Pipeline Report - a new market research report on companiesandmarkets.com ...

Below are three under the radar stocks from the healthcare sector that I have been following for the past 3-6 months which have upcoming catalysts in the form of expected strategic deals, clinical trial results, and other corporate developments.

HASBROUCK HEIGHTS, NJ Nymox Pharmaceutical Corporation announced today the release of positive new clinical trial data from responder analysis of the Company's pooled multicenter U.S. Phase 2 studies of NX-1207, indicating durable early responder benefits from Nymox's innovative drug treatment for benign prostatic hyperplasia .

Unapproved non-steroidal and tissue-selective anabolic drugs called selective androgen receptor modulators are being sold on the Internet as sports doping agents, according to a new report.

The availability of authentic SARMs was recently demonstrated for the first time by the detection of the drug candidate Andarine in a product sold via the Internet.

Nearly every man over 45 has some degree of enlargement of the prostate gland, which slowly progresses throughout the aging process.

Can a healthy lifestyle lower risk of benign prostate enlargement? Benign prostatic hyperplasia, known as BPH, is an enlargement of the prostate gland that is not malignant .

Sanofi-Aventis received a warning letter from the FDA's division of drug marketing, advertising, and communications after the company distributed a misleading promotional card for Uroxatral, an alpha1-blocker used to treat urinary problems caused by an enlarged prostate.

Two of the most common prostate problems are the Benign Prostatic Hyperplasia and the prostatitis.

The FDA today posted on its website a letter sent to Sanofi-Aventis regarding a voucher tent card for Uroxatral.

WYRE Foresta s MP is backing a campaign highlighting a prostate problem affecting more than a third of men aged over 50.

ADAM. "Benign Prostatic Hyperplasia In-Depth." 03 April 2007. HowStuffWorks.com. 13 October 2009.